Bone Biologics Corp. -CW26BBLGWPreferred / convertible
13F holders, Q2 2026 (June 30)2holders
0new positions
0sold out
1famous investor
$14.87avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Bone Biologics Corp. -CW26 (BBLGW) in their 13F filings, unchanged from Q1 2026. 0 opened new positions and 0 sold out. The largest holders were Citadel Advisors ($396K) and UBS Group AG ($4K). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Bone Biologics Corp. -CW26
- CUSIP
- 098070154
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2026 → Q2 2026: 91 shares bought and 3,354 shares sold, net −3,263 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Citadel Advisors | — | Reduce -11.3% | 26,398 | $396K |
| UBS Group AG | — | Add +21.6% | 513 | $4K |
"% of holder's portfolio" is BBLGW's weight in each manager's 13F, not the share of Bone Biologics Corp. -CW26 the manager owns.